U.S. Told to Spend $500M On Agricultural Biotech

WASHINGTON—The federal government ought to be spending $500 million a year by 1990 on competitive grants for research in agricultural biotechnology, a National Research Council committee has told the Department of Agriculture. In a report issued late last month, the Committee on a National Strategy for Biotechnology in Agriculture urged a major restructuring of U.S. agricultural research. It argued that the country needs much more emphasis on basic research and improved techniques and appl

Written byTabitha Powledge
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In a report issued late last month, the Committee on a National Strategy for Biotechnology in Agriculture urged a major restructuring of U.S. agricultural research. It argued that the country needs much more emphasis on basic research and improved techniques and applications in biotechnology, along with increased attention to biotechnology's ecological implications.

The committee strongly recommended institutional changes to achieve these goals. Among them is substantially increased competition for research funds. "A peer and merit review process must be used to assess and guide the development of the agricultural biotechnology research system, including all steps from basic science to extension," the report stated.

Of the roughly $2 billion in public money that supports agricultural research each year, only about $150 million comes from federal agencies in the form of competitive grants. The exact proportion that goes to biotechnology is unknown, but is believed to be very small. USDA's Agricultural Research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies